#5 - Cardinal Health (NYSE:CAH)
Healthcare is historically one of the purest of all the defensive sectors. Individuals still need their medications and demand for healthcare services doesn’t stop. Cardinal Health (NYSE:CAH) is an integrated health care provider with a pharmaceutical and a medical division. This helps the company capitalize on both areas of the demand equation.
CAH stock is up 18.8% since the onset of the pandemic in 2020, but arguably if you’re looking for growth you need a pretty wide lens. The company was named as a defendant in the nation’s first lawsuit that went to trial regarding the U.S. opioid addiction epidemic. A year after closing arguments, the company is still awaiting a verdict and it’s also dealing with higher input costs related to inflation.
But with Cardinal Health, investors will get paid a respectable dividend that the company has increased for the last 36 years making it a dividend aristocrat. And the stock is also trailing at an attractive 8x earnings.
About Cardinal Health
Cardinal Health, Inc operates as a healthcare services and products company in the United States, Canada, Europe, Asia, and internationally. It provides customized solutions for hospitals, healthcare systems, pharmacies, ambulatory surgery centers, clinical laboratories, physician offices, and patients in the home.
Read More - Current Price
- $108.52
- Consensus Rating
- Moderate Buy
- Ratings Breakdown
- 7 Buy Ratings, 4 Hold Ratings, 1 Sell Ratings.
- Consensus Price Target
- $120.18 (10.7% Upside)
